Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.

Vernuccio F, Godfrey D, Meyer M, Williamson HV, Salama JK, Niedzwiecki D, Stephens SJ, Ronald J, Palta M, Marin D.

AJR Am J Roentgenol. 2019 Oct 15:1-8. doi: 10.2214/AJR.18.20842. [Epub ahead of print]

PMID:
31613663
2.

Combining immunotherapy and radiotherapy for the STAR treatment.

Torok JA, Salama JK.

Nat Rev Clin Oncol. 2019 Sep 20. doi: 10.1038/s41571-019-0277-2. [Epub ahead of print] No abstract available.

PMID:
31541199
3.

Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.

Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC.

Pract Radiat Oncol. 2019 Sep - Oct;9(5):322-332. doi: 10.1016/j.prro.2019.06.016.

PMID:
31474330
4.

Authors' Reply.

Hong JC, Salama JK.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):xxxixa-xl. doi: 10.6004/jnccn.2019.7338. No abstract available.

PMID:
31390591
5.

Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?

Tay KJ, Polascik TJ, Howard LE, Salama JK, Schulman AA, Chen Z, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ.

Clin Genitourin Cancer. 2019 Oct;17(5):e930-e938. doi: 10.1016/j.clgc.2019.05.007. Epub 2019 May 24.

PMID:
31257075
6.

Retrospective analysis of safety and efficacy of anti-PD-1 therapy and radiation therapy in advanced melanoma: A bi-institutional study.

Mowery YM, Patel K, Chowdhary M, Rushing CN, Roy Choudhury K, Lowe JR, Olson AC, Wisdom AJ, Salama JK, Hanks BA, Khan MK, Salama AKS.

Radiother Oncol. 2019 Sep;138:114-120. doi: 10.1016/j.radonc.2019.06.013. Epub 2019 Jun 25.

PMID:
31252292
7.

Radiotherapy and Small Cell Carcinoma With Paraneoplastic Polyneuropathy: A Case Report.

Natarajan BD, Jacobs CD, Salama JK.

Ann Intern Med. 2019 Jun 25. doi: 10.7326/L19-0236. [Epub ahead of print] No abstract available.

PMID:
31234207
8.

Knowledge-Based Statistical Inference Method for Plan Quality Quantification.

Zhang J, Wu QJ, Ge Y, Wang C, Sheng Y, Palta J, Salama JK, Yin FF, Zhang J.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819857758. doi: 10.1177/1533033819857758.

9.

Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis.

Jacobs CD, Palta M, Williamson H, Price JG, Czito BG, Salama JK, Moravan MJ.

Front Oncol. 2019 Jun 4;9:469. doi: 10.3389/fonc.2019.00469. eCollection 2019.

10.

Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry.

Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK.

J Natl Compr Canc Netw. 2019 Feb;17(2):127-139. doi: 10.6004/jnccn.2018.7090.

PMID:
30787126
11.

Nonuniform Planning Target Volume Margins for Prostate Bed on the Basis of Surgical Clips on Daily Cone Beam Computed Tomography.

Song H, Salama JK, Lee WR, Wu Q.

Adv Radiat Oncol. 2018 Oct 12;4(1):186-190. doi: 10.1016/j.adro.2018.09.014. eCollection 2019 Jan-Mar.

12.

A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer.

Spiegel DY, Hong JC, Oyekunle T, Waters L, Lee WR, Salama JK, Koontz BF.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):834-842. doi: 10.1016/j.ijrobp.2018.11.007. Epub 2018 Nov 10.

PMID:
30419308
13.

Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration.

Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Moore H, Salama JK, Palta M.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):565-573. doi: 10.1016/j.ijrobp.2018.10.018. Epub 2018 Oct 22.

PMID:
30359718
14.

Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.

Chino F, Pollis KE, Choi S, Salama JK, Palta M.

Hepatology. 2018 Oct;68(4):1653-1655. doi: 10.1002/hep.30100. No abstract available.

PMID:
29888796
15.

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.

Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK.

PLoS One. 2018 Apr 12;13(4):e0195149. doi: 10.1371/journal.pone.0195149. eCollection 2018.

16.

Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens.

Tandberg DJ, Oyekunle T, Lee WR, Wu Y, Salama JK, Koontz BF.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):396-405. doi: 10.1016/j.ijrobp.2018.02.002. Epub 2018 Feb 8.

PMID:
29559284
17.

Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer.

Stephens SJ, Moravan MJ, Salama JK.

J Oncol Pract. 2018 Jan;14(1):23-31. doi: 10.1200/JOP.2017.026500.

PMID:
29324212
18.

Metastasis-Directed Therapy: Right for Some, but Not All, and Not Here.

Moravan MJ, Salama JK.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):767. doi: 10.1016/j.ijrobp.2017.03.047. No abstract available.

PMID:
29063845
19.

Radiotherapy for Oligometastatic Lung Cancer.

Bergsma DP, Salama JK, Singh DP, Chmura SJ, Milano MT.

Front Oncol. 2017 Sep 19;7:210. doi: 10.3389/fonc.2017.00210. eCollection 2017. Review.

20.

Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.

Boyer MJ, Williams CD, Harpole DH, Onaitis MW, Kelley MJ, Salama JK.

J Thorac Oncol. 2017 Dec;12(12):1814-1823. doi: 10.1016/j.jtho.2017.09.1952. Epub 2017 Sep 23.

21.

Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes.

Birer SR, Olson AC, Adamson J, Hood R, Susen M, Kim G, Salama JK, Kirkpatrick JP.

Med Dosim. 2017 Winter;42(4):310-316. doi: 10.1016/j.meddos.2017.06.007. Epub 2017 Jul 29.

PMID:
28760560
22.

Triphasic contrast enhanced CT simulation with bolus tracking for pancreas SBRT target delineation.

Godfrey DJ, Patel BN, Adamson JD, Subashi E, Salama JK, Palta M.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e489-e497. doi: 10.1016/j.prro.2017.04.008. Epub 2017 Apr 13.

PMID:
28666905
23.

ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.

Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK; Expert Panel on Radiation Oncology - Head and Neck Cancer.

Head Neck. 2017 Mar;39(3):407-418. doi: 10.1002/hed.24639. Epub 2016 Dec 29. Review.

24.

Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.

Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito BG, Hopkins MB, Palta M.

Cancer. 2017 Apr 15;123(8):1434-1441. doi: 10.1002/cncr.30461. Epub 2016 Dec 16.

25.

The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?

Hong JC, Salama JK.

Cancer Treat Rev. 2017 Jan;52:22-32. doi: 10.1016/j.ctrv.2016.11.003. Epub 2016 Nov 10. Review.

PMID:
27886588
26.

Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.

Al-Hallaq HA, Chmura SJ, Salama JK, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Robinson CG, Pisansky TM, Winter KA, White JR, Xiao Y, Matuszak MM.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):155-163. doi: 10.1016/j.ijrobp.2016.09.030. Epub 2016 Sep 28.

27.

Is a single isocenter sufficient for volumetric modulated arc therapy radiosurgery when multiple itracranial metastases are spatially dispersed?

Morrison J, Hood R, Yin FF, Salama JK, Kirkpatrick J, Adamson J.

Med Dosim. 2016 Winter;41(4):285-289. doi: 10.1016/j.meddos.2016.06.007. Epub 2016 Sep 7.

PMID:
27614790
28.

Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.

Hu F, Vishwanath K, Salama JK, Erkanli A, Peterson B, Oleson JR, Lee WT, Brizel DM, Ramanujam N, Dewhirst MW.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):462-469. doi: 10.1016/j.ijrobp.2016.06.007. Epub 2016 Jun 14.

29.

Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab.

Olson AC, Thomas S, Qin R, Singh B, Salama JK, Kirkpatrick J, Salama AK.

Melanoma Manag. 2016 Sep;3(3):177-186. doi: 10.2217/mmt-2016-0004. Epub 2016 Aug 22.

30.

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.

Seiwert TY, Melotek JM, Blair EA, Stenson KM, Salama JK, Witt ME, Brisson RJ, Chawla A, Dekker A, Lingen MW, Kocherginsky M, Villaflor VM, Cohen EE, Haraf DJ, Vokes EE.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):21-9. doi: 10.1016/j.ijrobp.2016.04.030. Epub 2016 May 7.

PMID:
27511844
31.

A Multidisciplinary Approach to Larynx Cancer: One Size Does Not Fit All.

Mowery YM, Salama JK.

J Oncol Pract. 2016 Aug;12(8):725-6. doi: 10.1200/JOP.2016.014803. No abstract available.

PMID:
27511719
32.

Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.

Torok JA, Gu L, Tandberg DJ, Wang X, Harpole DH Jr, Kelsey CR, Salama JK.

Clin Lung Cancer. 2017 Jan;18(1):e57-e70. doi: 10.1016/j.cllc.2016.06.011. Epub 2016 Jul 5.

PMID:
27477488
33.

Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management.

Correa RJ, Salama JK, Milano MT, Palma DA.

Cancer J. 2016 Jul-Aug;22(4):247-56. doi: 10.1097/PPO.0000000000000202.

PMID:
27441744
34.

Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer.

Boyer MJ, Gu L, Wang X, Kelsey CR, Yoo DS, Onaitis MW, Dunphy FR, Crawford J, Ready NE, Salama JK.

Lung Cancer. 2016 Aug;98:76-78. doi: 10.1016/j.lungcan.2016.05.014. Epub 2016 May 25.

PMID:
27393510
35.

Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab.

Qin R, Olson A, Singh B, Thomas S, Wolf S, Bhavsar NA, Hanks BA, Salama JK, Salama AK.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):72-7. doi: 10.1016/j.ijrobp.2016.04.017. Epub 2016 Apr 21.

PMID:
27375168
36.

Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.

Al-Hallaq HA, Chmura S, Salama JK, Winter KA, Robinson CG, Pisansky TM, Borges V, Lowenstein JR, McNulty S, Galvin JM, Followill DS, Timmerman RD, White JR, Xiao Y, Matuszak MM.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e291-e298. doi: 10.1016/j.prro.2016.05.004. Epub 2016 May 20.

37.

ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.

Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS; Expert Panel on Radiation Oncology - Head and Neck.

Head Neck. 2016 Sep;38(9):1299-309. doi: 10.1002/hed.24447. Epub 2016 Jun 22. Review.

38.

Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer.

Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ.

J Thorac Oncol. 2016 Oct;11(10):1672-81. doi: 10.1016/j.jtho.2016.05.030. Epub 2016 Jun 11.

39.

Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).

Wong AC, Watson SP, Pitroda SP, Son CH, Das LC, Stack ME, Uppal A, Oshima G, Khodarev NN, Salama JK, Weichselbaum RR, Chmura SJ.

Cancer. 2016 Jul 15;122(14):2242-50. doi: 10.1002/cncr.30058. Epub 2016 May 20.

40.

ACR Appropriateness criteria® for nasopharyngeal carcinoma.

Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom SS; Expert Panel on Radiation Oncology-Head and Neck Cancer.

Head Neck. 2016 Jul;38(7):979-86. doi: 10.1002/hed.24423. Epub 2016 Apr 30. Review.

PMID:
27131050
41.

Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?

Drazer MW, Salama JK, Hahn OM, Weichselbaum RR, Chmura SJ.

Expert Rev Anticancer Ther. 2016 Jun;16(6):625-32. doi: 10.1080/14737140.2016.1178577. Epub 2016 May 10. Review.

PMID:
27078719
42.

Treatment of Thymoma-Associated Myasthenia Gravis With Stereotactic Body Radiotherapy: A Case Report.

Lee CM, Lee JD, Hobson-Webb LD, Bedlack RS, Salama JK.

Ann Intern Med. 2016 Aug 16;165(4):300-1. doi: 10.7326/L15-0469. Epub 2016 Mar 15. No abstract available.

PMID:
26974367
43.

In Reply to Fiorino and Cozzarini.

Lewis SL, Patel PR, Palta M, Yoo DS, Salama JK.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):860-1. doi: 10.1016/j.ijrobp.2016.01.009. No abstract available.

PMID:
26972661
44.

Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?

Hong JC, Salama JK.

Transl Lung Cancer Res. 2016 Feb;5(1):126-33. doi: 10.3978/j.issn.2218-6751.2016.01.07.

45.

Irradiation and immunotherapy: From concept to the clinic.

Salama AK, Postow MA, Salama JK.

Cancer. 2016 Jun 1;122(11):1659-71. doi: 10.1002/cncr.29889. Epub 2016 Feb 23. Review.

46.

Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.

Lewis SL, Patel P, Song H, Freedland SJ, Bynum S, Oh D, Palta M, Yoo D, Oleson J, Salama JK.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):605-11. doi: 10.1016/j.ijrobp.2015.11.025. Epub 2015 Dec 2.

PMID:
26867889
47.

ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.

Koyfman SA, Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS.

Head Neck. 2016 Feb;38(2):175-82. doi: 10.1002/hed.24171.

48.

Physics considerations for single-isocenter, volumetric modulated arc radiosurgery for treatment of multiple intracranial targets.

Stanhope C, Chang Z, Wang Z, Yin FF, Kim G, Salama JK, Kirkpatrick J, Adamson J.

Pract Radiat Oncol. 2016 May-Jun;6(3):207-213. doi: 10.1016/j.prro.2015.10.010. Epub 2015 Oct 23.

PMID:
26723551
49.

Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).

Salama JK, Gu L, Wang X, Pang HH, Bogart JA, Crawford J, Schild SE, Vokes EE, Ready NE.

J Thorac Oncol. 2016 Mar;11(3):361-9. doi: 10.1016/j.jtho.2015.11.001. Epub 2015 Dec 24.

50.

Ablative Approaches for Pulmonary Metastases.

Boyer MJ, Ricardi U, Ball D, Salama JK.

Thorac Surg Clin. 2016 Feb;26(1):19-34. doi: 10.1016/j.thorsurg.2015.09.004. Review.

PMID:
26611507

Supplemental Content

Loading ...
Support Center